Health Literacy Among Caregivers of Children With IgE-mediated Allergy With Risk of Anaphylaxis
NCT ID: NCT04475003
Last Updated: 2020-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2020-09-30
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the study is to test the general knowledge of anaphylaxis. Furthermore we test the extent to which caregivers consider themselves able to recognize and to treat anaphylaxis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health Literacy for Children With Atopic Dermatitis and Their Caregivers
NCT01138761
Assessing the Effectiveness of a Health Literacy Intervention in the Workplace
NCT01103986
Decreasing Medication Errors by Caregivers Using a Health Literacy Intervention
NCT01294501
Health Literacy in Patients With Congestive Heart Failure
NCT00508716
Evaluating a Low-Literacy Discharge Medication Education Tool
NCT00408733
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Teaching
Teaching session about anaphylaxis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* minimum 18 years old.
* signed informed consent
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Algemeen Ziekenhuis Maria Middelares
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
dr. Jasmine Leus
Kinderarts
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jasmine S Leus
Role: PRINCIPAL_INVESTIGATOR
Algemeen Ziekenhuis Maria Middelares
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Algemeen Ziekenhuis Maria Middelares
Ghent, Oost-Vlaanderen, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MMS2020.017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.